| Literature DB >> 19721819 |
Bayani Uttara1, Ajay V Singh, Paolo Zamboni, R T Mahajan.
Abstract
Free radicals are common outcome of normal aerobic cellular metabolism. In-built antioxidant system of body plays its decisive role in prevention of any loss due to free radicals. However, imbalanced defense mechanism of antioxidants, overproduction or incorporation of free radicals from environment to living system leads to serious penalty leading to neuro-degeneration. Neural cells suffer functional or sensory loss in neurodegenerative diseases. Apart from several other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes calamitous role to neuro-degeneration. Though, oxygen is imperative for life, imbalanced metabolism and excess reactive oxygen species (ROS) generation end into a range of disorders such as Alzheimer's disease, Parkinson's disease, aging and many other neural disorders. Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue damage and subsequent cellular apoptosis. Antioxidants are now being looked upon as persuasive therapeutic against solemn neuronal loss, as they have capability to combat by neutralizing free radicals. Diet is major source of antioxidants, as well as medicinal herbs are catching attention to be commercial source of antioxidants at present. Recognition of upstream and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal damage as well as free radical scavenging. Antioxidants have a wide scope to sequester metal ions involved in neuronal plaque formation to prevent oxidative stress. In addition, antioxidant therapy is vital in scavenging free radicals and ROS preventing neuronal degeneration in post-oxidative stress scenario.Entities:
Keywords: ROS; amyloid; antioxidants; catalase; neurodegenerative diseases; oxidative stress; phagocytes.; rns
Year: 2009 PMID: 19721819 PMCID: PMC2724665 DOI: 10.2174/157015909787602823
Source DB: PubMed Journal: Curr Neuropharmacol ISSN: 1570-159X Impact factor: 7.363
Details of Prominent Antioxidant with their Class, Mechanism of Action and Referral of Neurodegenerative Disorder
| Class | Chemical Composition | Mechanism of Action | Neuronal Disorder Studied | Reference |
|---|---|---|---|---|
| Direct Antioxidant | Aryl amines and indoles-carotene, lycopene Polyenes- carotene, lycopene, retinol Selenium containing compounds ebselen. Polyphenols- Flavonoids, stilbenes, and hydroquinone Monophenols: tocopherols(vitamin E), 17-estradiol (estrogen), 5-hydroxytryptamine (serotonin) | direct chemical (nonenzymatic)scavenging of ROS generated free radicals and get some of them are recycled with endogenous oxidoreductases or via intracellular reducing shuttles | neuroprotection in Alzheimer’s disease | |
| Indirect antioxidant | Amino oxidase inhibitors, calcium antagonists, dopamine receptor agonists, glutamate receptor antagonists, ion chelators, nitric oxide synthase inhibitors | Prevent excitotoxicity, ROS and free radical generation targeting inhibitors and receptors dysregulating metal homeostasis | Parkinson’s disease and dementia | |
| Metabolic antioxidant | N-acetyl-cysteine, glutathione, 2-oxo-thiazolidine-4-carboxylate, and other thiol-delivering compounds | nullify cellular damage caused by free radicals by reducing secondary metabolic burden over cellular organelle(Mt, vesicles and cell membrane | Neuroprotection in general | |
| Metal containing antioxidant | Manganese-containing mimetics of catalase/superoxide dismutase | Enzymatic mimicking prevents protein-metal interaction | Mt protection in AD and PD |